Although relations between bHLH TF DEC1 and the DNA damage pathway have been shown (degradation of DEC1 controls the DNA damage response29), connections between E47, ID1, and ATR–CHK1 have not yet been exploited for therapeutic strategies in glioma. The gene discussed is ID1; the disease is central nervous system cancer.